Afya Limited Reports Strong Q2 2025 Financial Results and Expands Market Presence

Afya ( (AFYA) ) has provided an announcement.

On August 13, 2025, Afya Limited announced its financial results for the second quarter and first half of 2025, highlighting a 13.5% year-over-year revenue increase in Q2 to R$919.4 million and a 16.6% rise in adjusted EBITDA to R$400.8 million. The company also reported a significant expansion in its adjusted EBITDA margin and reaffirmed its full-year guidance. Afya’s acquisition of FUNIC, a new campus in Belo Horizonte, adds 60 medical seats, enhancing its market position. The company is also addressing the impacts of new taxation laws and has initiated a share repurchase program, reflecting its robust financial health and strategic confidence.

The most recent analyst rating on (AFYA) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on Afya stock, see the AFYA Stock Forecast page.

Spark’s Take on AFYA Stock

According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.

Afya’s overall stock score is driven by its strong financial performance and reasonable valuation, which are partially offset by bearish technical indicators. The earnings call provided positive insights into the company’s growth and strategic developments, although some operational challenges were noted. Technical analysis indicates potential for further downside, which dampens the overall score.

To see Spark’s full report on AFYA stock, click here.

More about Afya

Afya Limited is a leading medical education group and medical practice solutions provider in Brazil. The company focuses on delivering educational services and solutions for healthcare professionals, with a strong presence in the medical education sector.

Average Trading Volume: 114,895

Technical Sentiment Signal: Sell

Current Market Cap: $1.33B

For a thorough assessment of AFYA stock, go to TipRanks’ Stock Analysis page.